This paper introduces a domain generalization (DG) method for Diabetic Retinopathy (DR) classification that maximizes mutual information using a large pretrained model. The method aims to address the challenge of domain shift in medical imaging caused by variations in data acquisition. Experiments on public datasets demonstrate that the proposed method outperforms state-of-the-art techniques, achieving a 5.25% improvement in average accuracy.
This paper introduces a method for automatically designing convolutional neural network (CNN) architectures tailored for diabetic retinopathy (DR) diagnosis using fundus images. The approach uses k-medoid clustering, PCA, and inter/intra-class variations to optimize CNN depth and width. Validated on datasets including a local Saudi dataset and Kaggle benchmarks, the custom-designed models outperform pre-trained CNNs with fewer parameters.
KAUST and Saudi healthtech company amplifAI health have signed an MoU to develop a new disease detection system. The system will combine amplifAI's AI technology with KAUST's HyplexTM hyperspectral imaging, initially for diabetic foot complications. Clinical trials are planned, with aims to reduce amputations and save Saudi Arabia over 2 billion Riyals annually. Why it matters: This partnership showcases the potential of combining Saudi AI and advanced imaging technologies to address pressing healthcare challenges in the region, particularly diabetes.
Researchers have reportedly developed an artificial intelligence system capable of deblurring photographs. This AI aims to enhance image clarity by using advanced algorithms to reconstruct sharper images from blurry inputs. The technology could significantly improve visual quality across various applications where image capture is prone to blur. Why it matters: This development contributes to the broader field of computer vision and image processing, offering potential applications in areas from surveillance to professional photography.